GSK and UC San Diego form cancer stem cells pact – PharmaTimes
Newswise (press release) |
GSK and UC San Diego form cancer stem cells pact
PharmaTimes Research carried out by scientists at UC San Diego has shown that uncontrolled RNA editing helps cancer stem cells self-renew and produce more malignant cells in chronic myeloid leukaemia and other blood cancers. These stem cells can also lie dormant … UC San Diego and GSK Collaborate to Eradicate Cancer Stem Cells, Treat … GSK, UCSD team on blood cancers UC San Diego takes on project to eradicate cancer, treat leukemia |
